Professor, Department of Biotechnology, College of Life Science and Biotechnology, Yonsei University
Professor, Department of Biotechnology, College of Life Science and Biotechnology, Yonsei University
Chief Scientific Officer and Senior Vice President of R&D, NanoString Technologies
Physician-Scientist Training Program Department of Pathology and Laboratory Medicine Post-doctoral fellow, laboratory of Dr. John Wherry Institute for Immunology Department
Managing Director, KOL Network at LifeSci Advisors, LLC
Clinical Pathologist, Dept. of Pathology, Erasmus University Medical Center at Rotterdam
Medical Director of Multi-Organ Transplant Institute Section Head of Transplant Surgery, Ochsner Medical Center
Postdoctoral Fellow, Université de Nantes
Senior Product Enablement Scientist, NanoString Technologies
Leader of the Translational Immunology lab, The Institut Pasteur, Paris
Senior Product Manager, NanoString Technologies
Professor of Medicine, Associate Professor of Cell, Developmental and Integrative Biology (CDIB), University of Alabama
President and Professor at Institute for Systems Biology in Seattle
Associate Professor of Plastic Surgery; Wellcome Trust Fellow, the University of Oxford
Professor of Immunology at the University of York
Professor, Senior Scientist; Deputy Coordinator of Immunology Department, QIMR Berghofer
Research Scientist, Prevention of Organ Failure Center of Excellence (PROOF)
NHMRC Research Fellow, The University of Queensland
Chief Scientific Officer, Rosalind.Bio
Associate Professor; Director, WorldQuant Initiative for Quantitative Prediction, Weill Cornell Medicine
Chair and Medical Director for Laboratory Medicine and Pathology, at the University of Alberta and with Alberta Precision Laboratories Ltd. in Edmonton, Canada
Max Planck Research Unit for Neurogenetics
Assistant Professor, Group Leader of the Tumor Immuno-Pathology (TIP) Laboratory, Erasmus University Medical Center
Independent American broadcast news journalist
Associate Faculty, Institute of Molecular and Cell Biology (A*STAR) Singapore
Research Associate in Pathology, Massachusetts General Hospital
Senior Clinical Lecturer Centre for Inflammatory Disease Dept of Immunology and Inflammation Imperial College London Department of Medicine
Senior Global Marketing Manager, NanoString Technologies
Assistant Professor of Medicine, Weill Medical College of Cornell University
Senior Director, Translational Science, NanoString Technologies
Southern Medical University
302 Hospital of China
Europe - 9:00 AM Central European Summer Time
Americas - 9:00 AM Central Daylight Time
Asia-Pacific - 9:00 AM Beijing Standard Time (*September 15)
The immune system plays a major role in the onset and progression of different disorders such as autoimmunity, infectious disease, and organ rejection. Insights into the dynamics of the immune response, inflammation and tissue damage can help researchers better understand how to treat the immune system as well as disease symptoms to avoid systemic hyperinflammation and organ damage.
Join us for this virtual conference that brings together researchers, scientists, and clinicians from around the world to learn and discuss recent advances in immunology research with a focus on the latest topics and trends in infectious disease and organ transplantation. We will discuss the impact of the COVID-19 pandemic on these research areas as well as the role that gene expression profiling, both bulk and spatial, has in future discoveries.
Scientific tracks for this event include:
• Infectious Disease Research in a Post-COVID World
• Cell Therapy, Tissue Engineering, & More: What Lies Ahead for Organ Transplant
• Concurrent Data Analysis Sessions: GeoMx Tools/GeoScript Hub and the ROSALIND® Platform for nCounter data analysis
This free online event allows you to participate within the most convenient time for your location:
Americas: 9:00 AM Central Daylight Time
Europe: 9:00 AM Central European Summer Time
9:00 AM Beijing Standard Time, September 15
The webinars will be available for unlimited on-demand viewing for 6 months post-event.
About NanoString® Technologies, Inc.
NanoString Technologies is a leading provider of life science tools for translational research. The company’s nCounter® Analysis System is used in life sciences research and has been cited in more than 4,000 peer-reviewed publications. The nCounter® Analysis System offers a cost-effective way to easily profile the expression of hundreds of genes, proteins, miRNAs, or copy number variations, simultaneously with high sensitivity and precision, facilitating a wide variety of basic research and translational medicine applications, including biomarker discovery and validation. The company’s GeoMx® Digital Spatial Profiler enables highly-multiplexed spatial profiling of RNA and protein targets in a variety of sample types, including FFPE tissue sections. For more information, please visit www.nanostring.com.